Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtre
Ajouter des filtres








Gamme d'année
2.
Braz. j. med. biol. res ; 27(6): 1343-1346, June 1994.
Article Dans Anglais | LILACS | ID: lil-319770

Résumé

In the present study we characterized the cytotoxicity of Wistar rat mononuclear cells from 21 animals which received 10(6) Walker 256 tumor cells by the subcutaneous route. All animals developed the tumor. Cytotoxicity was studied 15 days after inoculation using spleen, thymus and lymph node T lymphocytes as well as macrophages from the peritoneal cavity. A Walker 256 tumor cell suspension and tumor cells in culture (YAC-1) were labelled with 51Cr and used as target cells, according to the Herberman technique and a gamma counter was used for counting. Anti-Walker cell cytotoxicity was significantly decreased in T lymphocytes from the spleen (9.6 vs 51.1 for the control) and thymus (11.5 vs 38.2 for the control), whereas no difference was observed for lymph nodes (41.2 vs 49.5 for the control) or macrophages (43.4 vs 46.3 for the control). Anti-YAC-1 cytotoxicity was significantly decreased in T lymphocytes from all lymphoid organs compared to control: 23.6 vs 42.8 for the spleen, 22.6 vs 41.1 for the thymus, 26.6 vs 42.1 for lymph nodes, and 27.1 vs 46.3 for macrophages. No correlation was observed between tumor weight, and anti-Walker cytotoxicity or anti-YAC-1 cytotoxicity.


Sujets)
Animaux , Rats , Carcinosarcome Walker 256 , Cellules tueuses naturelles/immunologie , Lymphocytes T , Cytotoxicité immunologique , Rat Wistar , Cellules cancéreuses en culture
3.
Braz. j. med. biol. res ; 27(1): 91-4, jan. 1994. tab
Article Dans Anglais | LILACS | ID: lil-136497

Résumé

Rhodium (II) trifluoracetate (TFARh), rhodium (II) trifluoracetate adduct with sulfadiazine (TFARh.Sd) and rhodium (II) acetate adduct with sulfisoxazole (RhSx) were tested in mice for acute toxicity, antitumoral activity against Ehrlich ascites carcinoma and for viability of Ehrlich tumor cells in culture. At ip doses up to 60 µmg/kg (40-70 and 59 mg/kg, respectively), these coumpounds had no toxic effects up to 14 days. At ip doses of 10 µmol Kg-1 day-1 for 5 days, TFARh and TFARh.Sd significantly increased the survival rate of mice bearing Ehrlich ascites cells (probability of survival to the end of 34th day, controls = 0.23, TFARh = 0.85, TFARh.Sd = 0.74). No significant effect was observed for RhSx. In vitro, these rhodium complexes at 40 µM significantly increased the number of dead cells in cultured Ehrlich tumor cells


Sujets)
Souris , Protocoles de polychimiothérapie antinéoplasique/pharmacologie , Carcinome d'Ehrlich/traitement médicamenteux , Techniques in vitro , Rhodium/pharmacologie , Acétates/administration et posologie , Carcinome d'Ehrlich/mortalité , Souris de lignée BALB C , Sulfadiazine/administration et posologie , Sulfafurazol/administration et posologie , Facteurs temps , Acide trifluoro-acétique/administration et posologie
4.
Braz. j. med. biol. res ; 22(3): 397-401, 1989. ilus, tab
Article Dans Anglais | LILACS | ID: lil-70701

Résumé

Rhodium II citrate was tested in mice for acute toxicity, antitumoral activity against Ehrlich ascites carcinoma and inhibition of DNA synthesis by Ehrlich tumor, malignant adrenocortical cells (Y-1) and normal adrenocortical cells (AR-1)_. At ip doses up to 260 mg/Kg, the compound had no toxic effects for up to 14 days. The same total dose given over 4 days significantly increased the survial rat of mice bearing Ehrlich ascites cells. Thymidine incorporation by Ehrlkich tumor, Y-1 cells in vitro was inhibited 50% by a.1 to 0.2 mM concentrations of the compound. We conclude that the increase survival of the tumor-bearing mice was due at least in part to the inhibition of DNA synthesis with a consequet reduction of cell division and tumor growth


Sujets)
Souris , Animaux , Carcinome d'Ehrlich/anatomopathologie , Citrates/pharmacologie , Rhodium/pharmacologie , Carcinome d'Ehrlich/mortalité , Citrates/toxicité , ADN/biosynthèse , Rhodium/toxicité
5.
Arq. méd. ABC ; 6(1/2): 14-16, 1983.
Article Dans Portugais | LILACS | ID: lil-19822

Résumé

Sao apresentados alguns aspectos basicos das linhagens celulares mais utilizadas nos nossos laboratorios de pesquisas. Quatro linhagens de origem humana e tres linhagens de origem animal sao descritas quanto a sua obtencao, meio de congelamento, meio de cultura, caracteristicas de crescimento e morfologia


Sujets)
Lignée cellulaire
6.
Arq. méd. ABC ; 5(1/2): 17-20, 1982.
Article Dans Portugais | LILACS | ID: lil-13246

Résumé

Neste trabalho visou-se estudar comparativamente as acoes comportamentais do naftil-azoderivado da sulfamerazina e da propria sulfamerazina. Observou-se que o naftil-azoderivado apresenta atuacao que comprometem o comportamento aprendido diminuindo as respostas em ratos condicionados. A movimentacao espontanea, observada em campo aberto, em camundongos sob acao do naftil-azoderivado, aumentou com o decorrer do tempo, tendo atingindo o seu maximo apos 24 horas da injecao intraperitoneal. A toxicidade aguda do naftil-azoderivado diminuiu em relacao a sulfamerazina, quando da determinacao da DL 50. O composto ja avaliado anteriormente continuou a apresentar atuacao antimicrobiana


Sujets)
Animaux , Mâle , Souris , Rats , Intoxication , Sulfamérazine , Comportement animal , Conditionnement psychologique , Injections péritoneales
SÉLECTION CITATIONS
Détails de la recherche